These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8840111

  • 1. Lack of relationship between insulin antibodies, metabolic control and insulin requirements in type 1 diabetes.
    Fernández Castañer M, Pérez M, Maravall J, Montaña E, Soler J.
    Diabet Med; 1996 Jul; 13(7):686-7. PubMed ID: 8840111
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B, Muche R, Riegger I, Moritz M, Heinze E, Debatin KM, Wabitsch M, Karges W.
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul 03; 48(1238):54-5. PubMed ID: 16841022
    [Abstract] [Full Text] [Related]

  • 11. [The influence of clinical presentation and metabolic control of insulin dependent diabetes in the evolution of residual insulin secretion. A prospective study at five years].
    Fernández Castañer M, Gonzálbez J, Carrera MJ, Nacher V, Montanya E, Abós R, Soler J.
    Med Clin (Barc); 1997 Sep 20; 109(9):328-32. PubMed ID: 9379763
    [Abstract] [Full Text] [Related]

  • 12. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec 20; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL, Meloche RM, Thompson D, Shapiro RJ, Fung M, Ao Z, Ho S, He Z, Dai LJ, Young L, Blackburn L, Kozak S, Kim PT, Al-Adra D, Johnson JD, Liao YH, Elliott T, Verchere CB.
    Arch Surg; 2005 Aug 20; 140(8):735-44. PubMed ID: 16103282
    [Abstract] [Full Text] [Related]

  • 18. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS, McLaughlin T, Loza L, Beauchamp R, Schwartz S, Kipnes M.
    Curr Med Res Opin; 2004 Nov 20; 20(11):1703-10. PubMed ID: 15537471
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study of 2 therapeutic regimens using fractionated doses of insulin in insulin-dependent diabetics].
    Hajri S, Ben Slama CL, Chamakhi S, Bessioud M, Mebazaa R, Boukhris R.
    Tunis Med; 1985 Nov 20; 63(11):589-93. PubMed ID: 3835734
    [No Abstract] [Full Text] [Related]

  • 20. Improved metabolic control preserved beta-cell function two years after diagnosis of insulin-dependent diabetes mellitus.
    Montanya E, Fernandez-Castañer M, Soler J.
    Diabetes Metab; 1997 Sep 20; 23(4):314-9. PubMed ID: 9342545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.